Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

计划入组 15 人 · 首次发布于 2016 年 9 月 12 日

Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers

计划入组 5,966 人 · 首次发布于 2016 年 7 月 29 日

Safety and Tolerability of PRO 140 in HIV Uninfected Male Volunteers

计划入组 20 人 · 首次发布于 2005 年 5 月 11 日

Oligo-nucleotide against Pro-opiomelanocortin

Pro-Pro-Thr-Val-Pro-Thr-Arg

C₃₄H₅₈N₁₀O₁₀

PRO-1286

PRO-IMPLANT Foundation

Germany

Alpha Pro Tech

Pro Top & Mediking Company Limited

Novo Nordisk's Cagrilintide/Semaglutide Combo Shows Superior Weight Loss in Phase III Trial

Setmelanotide Shows Promise in Reducing Obesity in Young Children With Rare Genetic Deficiencies

Unexplained Skin Darkening Leads to Life-Saving Addison's Disease Diagnosis in 24-Year-Old Woman